KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) EPS (Basic) (2016 - 2025)

Emergent BioSolutions (EBS) has 16 years of EPS (Basic) data on record, last reported at -$1.01 in Q4 2025.

  • For Q4 2025, EPS (Basic) fell 77.19% year-over-year to -$1.01; the TTM value through Dec 2025 reached $0.98, up 127.37%, while the annual FY2025 figure was $0.98, 127.22% up from the prior year.
  • EPS (Basic) reached -$1.01 in Q4 2025 per EBS's latest filing, down from $0.96 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $3.32 in Q4 2021 and bottomed at -$5.38 in Q2 2024.
  • Average EPS (Basic) over 5 years is -$0.88, with a median of -$0.59 recorded in 2024.
  • Peak YoY movement for EPS (Basic): soared 645.83% in 2021, then plummeted 4022.22% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at $3.32 in 2021, then plummeted by 137.65% to -$1.25 in 2022, then grew by 28.0% to -$0.9 in 2023, then surged by 36.67% to -$0.57 in 2024, then crashed by 77.19% to -$1.01 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$1.01 in Q4 2025, $0.96 in Q3 2025, and -$0.22 in Q2 2025.